Emergency Medicine Australasia · 2008 · 35 citations · 22 references
MedicinePharmacologyPharmacotherapyBehavioral MedicineIntravenous SedationPsychopharmacologyEmergency SedationSedation ManagementSedation ProtocolsSedative PharmacologyGlasgow Coma Scale AssessmentIntravenous Midazolam SedationMidazolam InfusionMidazolam PremedicationMidazolam UsePsychostimulant PharmacotherapySedation For Agitated PatientsSedation In Emergency Medicine
OBJECTIVES: To trial high-dose midazolam sedation protocol for uncooperative patients with suspected psychostimulant-induced behavioural disorders. End-points were effectiveness and safety. METHODS: A prospective pilot study was undertaken with a convenience sample of adult, uncooperative patients with suspected psychostimulant-induced severe behavioural disorders. The protocol was midazolam in 10 mg increments, i.m. or i.v., at 10 min intervals, up to four doses and titrated to an end-point of rousable drowsiness. RESULTS: Sixty-two patients were enrolled. Two-thirds of the patients required only one dose of midazolam; 88% of the sample were sedated with two doses. Six and a half per cent of patients were not sedated after four doses. A Glasgow Coma Score of eight or less was prolonged in eight patients. Airway problems requiring an adjunct were present in four patients. Recent psychostimulant use was present in only 55% after full assessment. CONCLUSIONS: High-dose midazolam protocols cannot be supported as universally safe. High-dose protocols for severe behavioural disturbance are not more effective, with failures occurring even after repeated dosing.
22
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
C.-K. CHEN, Shih‐Ku Lin, Pak C. Sham et al. · Psychological Medicine · 2003 · 297 citations
Medicine, Psychiatry, Psychology +17
Marc L. Martel, Ann Sterzinger, James R. Miner et al. · Academic Emergency Medicine · 2005 · 158 citations · Full text